ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,930, issued on Aug. 25, was assigned to BIO-THERA SOLUTIONS LTD. (Guangdong, China).
"Use of anti-OX40 antibody in treatment of tumor or cancer" was invented by Shizhong Liang (Guangzhou, China), Binghui Liang (Guangzhou, China), Jin-Chen Yu (Guangzhou, China), Xiao Li (Guangzhou, China), Shuqiang Song (Guangzhou, China) and Shengfeng Li (Guangzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The use of an anti-OX40 antibody or an antigen-binding fragment in the treatment of a tumor or cancer, is described. Also described is a treatment method of a tumor or cancer and includes administering to a patient in need an effective amount of an ant...